Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Epidermal growth factor helps hair regrow after chemotherapy.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Procyanidins may have antioxidant, heart health, cancer-fighting, anti-inflammatory, anti-diabetic, liver-protective, and other health benefits with high efficiency and low toxicity.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Cepharanthine shows promise as a COVID-19 treatment.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Enhancing immune response can improve cancer treatment effectiveness.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Drug repurposing finds new uses for existing drugs, saving time and money.

The committee decided not to approve the drug due to low effectiveness and high risks.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Soy foods may lower colon cancer risk.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.